



 
 
 


 

Michael J. Vogelzang 
President and Chief Investment Officer
 

Mr. Vogelzang is President and Chief Investment Officer of Boston Advisors. Mr. Vogelzang has managed Boston Advisors since 1997 and led the firm's management buyout in 2006. As President and CIO, he is responsible for overseeing the firm’s equity, fixed-income and alternative investment activities, risk management strategy and general business practices. In his role as the firm's Managing Member, he also chairs the independent Board of Directors. 



Professionally, Mr. Vogelzang served as the President and Trustee of the multi-billion dollar Boston Advisors Trust, a family of money market mutual funds. He also held the role of President of the Lebenthal Funds, a taxable and tax-exempt family of long-term bond funds. He served as a board member for Advest, Inc., the one-time parent company of Boston Advisors. Prior to joining Boston Advisors, Mr. Vogelzang held senior positions with Freedom Capital Management and Shawmut Investment Management, and he began his investment career at The Boston Company.


Mr. Vogelzang chairs the investment committee of the Barnabas Foundation, a large, Chicago-based, planned giving and estate planning charitable organization, investing on behalf of faith-based organizations. Mr. Vogelzang earned a B.A. degree in economics and political science from Calvin College in Grand Rapids, MI and attended Boston University's Graduate School of Management. He holds the Chartered Financial Analyst (CFA) designation and is a member of the CFA Society Boston. As an investment strategist, he is frequently invited to speak at industry conferences, interview in the financial media and contribute articles to portfolio management journals.











 
 

Boston Advisors, LLC


















Skip to main content.





Global Navigation




For Businesses
For Financial Advisors
En Español

1-877 On Your Side® Contact Us



Show Search









Log In or Sign Up
        


Privacy and Security
Individuals:




Select Account
Annuity
Banking
Deferred Compensation
Group Accident Medical
Insurance
Life Insurance
Mortgage
Mutual Funds
Retirement Plans


Have your username and password ready and press the Log In button.








Remember username



close help messageX
open help message?




                      Do not select if you are using someone else's device, such as a public computer at the library.
                    




Sign Up for Account Access
Forgot Your Username?
Forgot Your Password?
Forgot Username/Password?




Log in to my account
Sign me up
Privacy & Security




Businesses & Partners
Individuals

Businesses & Partners


Businesses


Financial Advisor & Investment Firm


Plan Sponsor & Service Provider


Deferred Compensation


Pension Administrator


Specialty Insurance


Nationwide Supplier












Home


Retirement & Investing

Mutual Funds

Pricing & Performance

Subadviser 




Boston Advisors, LLC



Nationwide



Call 1-800-848-0920


Find a Financial Advisor




Boston Advisors, LLC

Boston Advisors, LLC is an independent, quantitatively disciplined investment firm that delivers innovative, thoughtfully applied solutions with the aim of providing consistent results to both the world's largest institutional investors and high-net-worth individual investors. Boston Advisors, LLC has over $4.5 billion in assets under management and is a subadviser of Nationwide Funds®.
Douglas A. Riley, CFA
Senior Vice President & Director of Growth Equity Investing

Nationwide Growth Fund
Mr. Riley is Senior Vice President and Director of Growth Equity Investing at Boston Advisors. Mr. Riley brings more than twenty-five years of industry-related experience to Boston Advisors. As a member of the Institutional Equity Team, Mr. Riley has primary responsibility for the firm's growth equity strategies.
Mr. Riley earned a B.S. degree in business administration and finance from Emory University and a M.B.A. degree from Northeastern University. He holds the Chartered Financial Analyst (CFA) designation, and is a member of the CFA Institute and of the CFA Society Boston.
Michael J. Vogelzang, CFA
President & Chief Investment Officer  

Nationwide Growth Fund
Mr. Vogelzang is President and Chief Investment Officer of Boston Advisors. Mr. Vogelzang has managed Boston Advisors since 1997 and led the firm's management buyout in 2006. As President and CIO, he is responsible for overseeing the firm’s equity, fixed-income and alternative investment activities, risk management strategy and general business practices. In his role as the firm's Managing Member, he also chairs the independent Board of Directors.
Mr. Vogelzang earned a B.A. degree in economics and political science from Calvin College in Grand Rapids, MI and attended Boston University's Graduate School of Management. He holds the Chartered Financial Analyst (CFA) designation and is a member of the CFA Society Boston.
David Hanna
Senior Vice President & Director of Institutional Portfolio Management

Nationwide Growth Fund
Mr. Hanna is Senior Vice President and Director of Institutional Portfolio Management at Boston Advisors. In his role, Mr. Hanna oversees the firm’s equity and alternative investment activities. He also serves as lead portfolio manager for the firm’s small cap value strategy and is a member of the portfolio team managing the firm’s global tactical asset allocation (GTAA) strategy, where he focuses on commodities and currencies. Mr. Hanna has specific expertise in the areas of quantitative research and alternative investments. He contributes to the development of the firm’s proprietary quantitative models, specifically the stock selection, asset class selection, market profiling and risk assessment models. He also directs decisions around alternative investments, including alternative asset class allocations, hedging and derivatives.
Mr. Hanna earned a B.S. degree in finance from the Pennsylvania State University in 1987 and completed an honors degree with a thesis on derivatives hedging entitled, "Portfolio Insurance - A Simulation Using Binomial Option Pricing Theory." He also attended the Institut Universitaire de Technologie in Nice, France, focusing on European business.
Edward Mulrane, CFA
Vice President, Director of Quantitative Research
Nationwide Growth Fund
Mr. Mulrane is a Vice President and Director of Quantitative Research at Boston Advisors. Mr. Mulrane manages the group responsible for proprietary model research and development at the firm. The group focuses on stock, asset class, market and risk modeling for traditional and alternative investment management efforts. Mr. Mulrane is a member of the portfolio management team for Boston Advisors’ suite of global tactical asset allocation (GTAA) products and serves as lead portfolio manager for the Dynamic Risk Parity strategy. He also contributes to the development of investment technology and processes for the firm.
Mr. Mulrane earned a B.S and M.S. in computer engineering from Rochester Institute of Technology and an M.B.A. with High Honors and an M.S. in mathematical finance, both from Boston University. Mr. Mulrane holds the Chartered Financial Analyst (CFA) designation and is a member of the CFA Society Boston and the CFA Institute. 






Share Article















NFW-4108AO.4


Home


Retirement & Investing

Mutual Funds

Pricing & Performance

Subadviser 







click to access additional linksRetirement



Retirement  Plans…
401(k) Plans
403(b) Plans
457 Plans




Mutual  Funds…
Pricing & Performance
NVIT Funds
Shareholder News




  Annuities…
Fixed Annuities
Variable Annuities
Immediate Annuities
Fixed Indexed Annuities




Life  Insurance…
Term Life Insurance
Whole Life Insurance
Universal Life Insurance
Variable Universal Life Insurance






NFW-4371AO.6











 
 

What are Mutual Funds? | Investing in Mutual Funds | Nationwide.com


















Skip to main content.





Global Navigation




For Businesses
For Financial Advisors
En Español

1-877 On Your Side® Contact Us



Show Search









Log In or Sign Up
        


Privacy and Security
Individuals:




Select Account
Annuity
Banking
Deferred Compensation
Group Accident Medical
Insurance
Life Insurance
Mortgage
Mutual Funds
Retirement Plans


Have your username and password ready and press the Log In button.








Remember username



close help messageX
open help message?




                      Do not select if you are using someone else's device, such as a public computer at the library.
                    




Sign Up for Account Access
Forgot Your Username?
Forgot Your Password?
Forgot Username/Password?




Log in to my account
Sign me up
Privacy & Security




Businesses & Partners
Individuals

Businesses & Partners


Businesses


Financial Advisor & Investment Firm


Plan Sponsor & Service Provider


Deferred Compensation


Pension Administrator


Specialty Insurance


Nationwide Supplier












Home


Retirement & Investing

Mutual Funds















NFW-5468AO


Nationwide Market Insights
Meeting with your financial advisor? Be ready to discuss these current topics.
View  topics… 


 









NFW-3977AO


Do You Have a
Retirement Date in Mind?
We can help you make your date a reality.
Find out how  … 


 





Nationwide



Call Us For Assistance




Shareholder Services
1-800-848-0920


Financial Advisors
1-877-877-5083, option 3 






Find a Financial Advisor




Find a Financial Advisor
Find an Agent
Find a Mortgage Expert



Call to find a financial advisor: 
1-877-245-0761



 



NFW-3320AO
What type of mutual fund is right for you?

Mutual funds – professionally managed investment programs that trade in diversified holdings – can be a highly effective tool for savings and growing your assets. On these pages, you can learn more about the various types of mutual funds available through Nationwide. 

Types of mutual funds
Review our full range of mutual fund choices. 



Find a Fund

Search by:












Featured Funds









All Funds A-Z









Funds by Asset Class


















Fund of Funds


















4 & 5 Star Rated





















Why Nationwide Funds? We offer you resources that break down complicated investment topics into language that can fuel more meaningful conversations about your  future.…













Mutual Fund Sales Charges Find out what percentage of mutual fund purchases go to sales  fees.…






NFW-3631AO.1, NFW-6642AO









Social Security and Your Retirement Plan Work with a financial advisor to develop your filing  strategy.…














Tools & Calculators Use our planners, analyzers and calculators to help make investment  decisions.…






NFW-5617AO, NFW-3297AO






Share Article















NFW-2929AO.7


Home


Retirement & Investing

Mutual Funds







click to access additional linksRetirement



Retirement  Plans…
401(k) Plans
403(b) Plans
457 Plans




Mutual  Funds…
Pricing & Performance
NVIT Funds
Shareholder News




  Annuities…
Fixed Annuities
Variable Annuities
Immediate Annuities
Fixed Indexed Annuities




Life  Insurance…
Term Life Insurance
Whole Life Insurance
Universal Life Insurance
Variable Universal Life Insurance






NFW-4371AO.6













Pricing and Performance | Nationwide.com




























For Businesses
For Financial Advisors
En Español


1-877 On Your Side®









Log In or Sign Up

Privacy and SecurityIndividuals:


Select Account
Annuity
Banking
Deferred Compensation
Group Accident Medical
Insurance
Life Insurance
Mortgage
Mutual Funds
Retirement Plans

Have your username and password ready and press the Log In button.



 Sign Up for Account Access Forgot Your Username? Forgot Your Password? 



Log in to my account
Sign me up
Privacy & Security


Businesses & PartnersIndividuals
Businesses & Partners

Businesses
Financial Advisor &Investment Firm
Plan Sponsor &Service Provider
Deferred Compensation
Pension Administrator
Specialty Insurance
Nationwide Supplier




Contact Us


Skip to Main Content





Home
Retirement & Investing
Mutual Funds
Pricing & Performance






Pricing & Performance



Nationwide Mutual Funds

CURRENT PERFORMANCE MAY BE LOWER OR HIGHER THAN THE PAST PERFORMANCE SHOWN, WHICH DOES NOT GUARANTEE FUTURE RESULTS. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares.
To obtain further information on Nationwide Funds, call 1-800-848-0920 to request a summary prospectus and/or a prospectus. These prospectuses outline investment objectives, risks, fees, charges and expenses, and other information that you should read and consider carefully before investing.
The Nationwide Mutual Funds described in this site are sold only to persons residing in the United States. There is no assurance that the investment objective of any fund will be achieved. Investing in mutual funds involves risk, including the possible loss of principal.
Learn More about Sales Charges, Share Classes, Morningstar Ratings & Lipper Rankings  







Asset Class/Fund Group

All Asset Classes
International
Small Cap
Mid Cap
Large Cap
Asset Allocation
Fixed Income
All Fund Groups
Target Destination Funds
Equity Funds
Investor Destination Funds
Fixed-Income Funds
Index Funds
Alternative Funds



Search






Performance

Monthly w/ Sales Charge
Monthly at NAV
Quarterly w/ Sales Charge
Quarterly at NAV



Share Class



w/ Morningstar & Lipper














Read this important information
Performance represents average annual total returns, assumes the reinvestment of all distributions and reflects applicable sales charges. Total returns reflect a waiver of part of each Fund’s fees for certain periods since inception, without which returns would have been lower. Average annual total returns illustrate the annual compounded returns that would have produced the cumulative total return if each Fund’s performance had remained constant throughout the period indicated. Returns for periods less than one year are not annualized.
Expense Ratios
Expense ratios are as of the most recent prospectus. The difference between gross and net operating expenses reflects contractual fee waivers. Please see the Fund's prospectus for more detail. Expense ratios for Nationwide Bond Fund, Nationwide Government Bond Fund, Nationwide HighMark Bond Fund, Nationwide HighMark Small Cap Core Fund and Nationwide U.S. Small Cap Value Fund have been restated to reflect the reduction of contractual advisory fees effective May 1, 2017. The difference between gross and net operating expenses reflects contractual expense waivers in place through February 28, 2018 for all Funds except, Nationwide Loomis All Cap Growth Fund with waivers in place through February 28, 2019. Please see the Fund's prospectus for more details.
Class A
Except as noted below, Class A shares have up to a 5.75% front-end sales charge and a 12b-1 fee of 0.25%.
Nationwide Core Plus Bond Fund and Nationwide High Yield Bond Fund Class A shares have up to a 4.25% front-end sales charge and a 0.25% 12b-1 fee. 
Nationwide Amundi Global High Yield Fund, Nationwide Amundi Strategic Income Fund, Nationwide Amundi World Bond Fund, Nationwide Bond Fund, Nationwide Bond Index Fund, Nationwide Emerging Markets Debt Fund, Nationwide Government Bond Fund, Nationwide HighMark Bond Fund, Nationwide HighMark California Intermediate Tax Free Bond Fund, Nationwide HighMark National Intermediate Tax Free Bond Fund, Nationwide HighMark Short Term Bond Fund, Nationwide Inflation-Protected Securities Fund,  Nationwide Portfolio Completion Fund and Nationwide Ziegler Wisconsin Tax Exempt Fund Class A shares have up to a 2.25% front-end sales charge and a 0.25% 12b-1 fee. 
Investors may be able to reduce or eliminate front-end sales charges on Class A shares based on investment size. Please consult the most recent prospectus for the respective Fund for more details. 
Class C
Except as noted below, Class C shares have a 1.00% contingent deferred sales charge (CDSC) and a 1.00% 12b-1 fee. 
Nationwide High Yield Bond Fund Class C shares have a 0.75% CDSC and a 0.75% 12b-1 fee. 
Nationwide HighMark Bond Fund, Nationwide HighMark California Intermediate Tax Free Bond Fund, Nationwide HighMark National Intermediate Tax Free Bond Fund, Nationwide HighMark Short Term Bond Fund and Nationwide Ziegler Wisconsin Tax Exempt Fund Class C shares have a 1.00% CDSC and a 0.75% 12b-1 fee.
Class R
Class R shares have no sales charge and a 0.50% 12b-1 fee. 
Class R6 (Formerly called Institutional, Class I shares)
Class R6 shares have no sales charge and no 12b-1 fee. 
Institutional Service Class
Institutional Service Class shares have no sales charge and no 12b-1 fee. 
Service Class
Except as noted below, Service Class shares have no sales charge and a 0.25% 12b-1 fee.
Nationwide Government Money Market Fund Service Class shares have no sales charge and up to a 0.15% 12b-1 fee.
Investor Shares
Nationwide Government Money Market Fund Investor shares have no sales charge and no 12b-1 fee.  
Additional disclosures
Returns prior to the first offering of a specific share class of a Fund are based on the previous performance of other share classes of that Fund as noted below. This performance is substantially similar to what the specific share class would have produced because all share classes of a Fund invest in the same portfolio of securities. Performance assumes the reinvestment of all dividends and distributions. Performance has not been adjusted to reflect differences in applicable sales charges for individual classes, which if reflected may have resulted in higher or lower performance for the specific share class. Performance has been adjusted to reflect different expense levels for individual classes.
Class A
Nationwide Bailard Cognitive Value Fund, Nationwide Bailard International Equities Fund, Nationwide Bailard Technology & Science Fund, Nationwide Geneva Mid Cap Growth Fund, Nationwide HighMark Bond Fund, Nationwide HighMark California Intermediate Tax Free Bond Fund, Nationwide HighMark Large Cap Core Equity Fund, Nationwide HighMark National Intermediate Tax Free Bond Fund, Nationwide HighMark Small Cap Core Fund, Nationwide Ziegler Equity Income Fund, Nationwide Ziegler NYSE Arca Tech 100 Index Fund and Nationwide Ziegler Wisconsin Tax Exempt Fund Class A performance prior to each Fund’s inception (9/16/13) is based on performance of Class A shares of each Fund’s predecessor fund. Nationwide Core Plus Bond Fund Class A performance prior to inception (4/24/13) is based on the Fund’s Class R6 shares (which is based on performance of the Fund’s predecessor Fund). Nationwide Geneva Small Cap Growth Fund Class A performance is based on performance of Class A shares of the Fund’s predecessor fund from 6/12/09 to 9/16/13. Nationwide Global Sustainable Equity Fund (formerly Nationwide Global Equity Fund) and Nationwide High Yield Bond Fund Class A performance prior to inception (11/19/12) is based on performance of Class A shares of each Fund’s predecessor fund.
Class C
Nationwide Geneva Mid Cap Growth Fund and Nationwide Ziegler NYSE Arca Tech 100 Index Fund Class C performance is based on performance of Class A shares of each Fund’s predecessor fund through 6/8/09 and on performance of Class C shares of each Fund’s predecessor fund from 6/9/09 to 9/16/13. Nationwide Geneva Small Cap Growth Fund Class C performance is based on performance of Class C shares of the Fund’s predecessor fund from 6/12/09 to 9/16/13. Nationwide Global Sustainable Equity Fund (formerly Nationwide Global Equity Fund) and Nationwide High Yield Bond Fund performance prior to each Fund’s inception (11/19/12) is based on performance of Class C shares of each Fund's predecessor fund. Nationwide Bailard Cognitive Value Fund, Nationwide Bailard International Equities Fund, Nationwide Bailard Technology & Science Fund, Nationwide HighMark Bond Fund, Nationwide HighMark California Intermediate Tax Free Bond Fund, Nationwide HighMark Large Cap Core Equity Fund, Nationwide HighMark National Intermediate Tax Free Bond Fund, Nationwide HighMark Small Cap Core Fund and Nationwide Ziegler NYSE Arca Tech 100 Index Fund Class C performance prior to each Fund’s inception (9/16/13) is based on performance of Class C shares of each Fund's predecessor fund. Nationwide Ziegler Equity Income Fund and Nationwide Ziegler Wisconsin Tax Exempt Fund Class C performance is based on performance of Class A shares of each Fund’s predecessor fund through 6/8/09 and on performance of Class C shares of each predecessor fund from 6/9/09 to 9/16/13.
Class R6 (Formerly called Institutional, Class I shares)
Nationwide Core Plus Bond Fund Class R6 performance prior to inception (4/22/13) is based on performance of the Fund's predecessor fund. Nationwide Geneva Mid Cap Growth Fund, Nationwide Ziegler Equity Income Fund, Nationwide Ziegler NYSE Arca Tech 100 Index Fund and Nationwide Ziegler Wisconsin Tax Exempt Fund Class R6 performance from 6/8/09 to 9/18/13 is based on performance of the Fund’s Institutional Service Class shares (which is based on performance of the predecessor fund’s Fiduciary Class shares). Nationwide Geneva Small Cap Growth Fund Class R6 performance from 6/12/09 to 9/18/13 is based on performance of the Fund’s Institutional Service Class shares (which is based on performance of the predecessor fund’s Fiduciary Class shares). Nationwide Bailard Cognitive Value Fund, Nationwide Bailard International Equities Fund, Nationwide Bailard Technology & Science Fund,  Nationwide HighMark Bond Fund, Nationwide HighMark California Intermediate Tax Free Bond Fund, Nationwide Large Cap Core Equity Fund, Nationwide HighMark National Intermediate Tax Free Bond Fund, Nationwide HighMark Small Cap Core Fund Class R6 performance prior to inception (9/18/13) is based on performance of the Fund’s Institutional Service Class shares (which is based on performance of the predecessor fund’s Fiduciary Class shares). Prior to March 1, 2017, Class R6 was named "Institutional Class."
Institutional Service Class
Nationwide Geneva Mid Cap Growth Fund, Nationwide Ziegler Equity Income Fund, Nationwide Ziegler NYSE Arca Tech 100 Index Fund and Nationwide Ziegler Wisconsin Tax Exempt Fund Institutional Service Class performance is based on performance of the Fiduciary Class shares of each Fund's predecessor fund from 6/8/09 to 9/16/13. Nationwide Geneva Small Cap Growth Fund Institutional Service Class performance is based on performance of the Fiduciary Class shares of the Fund's predecessor fund from 6/12/09 to 9/16/13. Nationwide Global Sustainable Equity Fund (formerly Nationwide Global Equity Fund) and Nationwide High Yield Bond Fund Class R6 performance prior to inception (11/19/12) is based on performance of each Fund's Class R6 shares. Nationwide Growth Fund Institutional Service Class performance prior to inception (11/30/11) is based on performance of the Fund’s Class R6 shares. Nationwide Bailard Cognitive Value Fund, Nationwide Bailard International Equities Fund, Nationwide Bailard Technology & Science Fund, Nationwide HighMark Bond Fund, Nationwide HighMark California Intermediate Tax Free Bond Fund, Nationwide Large Cap Core Equity Fund, Nationwide HighMark National Intermediate Tax Free Bond Fund and Nationwide HighMark Small Cap Core Fund Institutional Service Class performance prior to inception (9/16/13) is based on performance of the Fiduciary Class shares of each Fund's predecessor fund.
Morningstar Ratings disclosure
Morningstar Ratings reflect risk-adjusted performance. The Morningstar RatingTM is derived from a weighted average of the performance figures associated with the Fund's 3-, 5- and 10-year (if applicable) periods.
Morningstar Ratings metrics. Morningstar Ratings are based solely on a proprietary mathematical formula based on measures of risk and performance that it recalculates each month. The ratings formula measures the amount of variation in a fund's or ETF’s monthly performance (including the effects of sales charges, loads and redemption fees) emphasizing downward variations and rewarding consistency. Ratings are subject to change every month. The top 10% of funds and ETFs in the category receive 5 stars; the next 22.5%, 4 stars; the next 35%, 3 stars; the next 22.5%, 2 stars; and the bottom 10%, 1 star. As of November 1, 2016, Morningstar will no longer provide ratings for load-adjusted share classes.
Ratings are based on specific class performance of each fund. Ratings are based on specific class performance of each fund. Current fund performance may be higher or lower, which may change a fund’s star rating. Despite high ratings, funds may have experienced negative performance during the period. Performance may reflect a waiver of part of a fund’s fees for certain periods since inception, without which returns would have been lower.
Ratings (with load) reflect class-specific sales charges, if any. A class share ratings no longer reflect sales charges. As of November 1, 2016, Morningstar will no longer provide ratings for load-adjusted share classes.
© 2017 Morningstar.  All Rights Reserved.  The information contained herein:  (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Lipper Rankings disclosure
Lipper Analytical Services, Inc. (Lipper) is an industry research firm whose rankings are based on total return performance and do not reflect the effect of sales charges. Each fund is ranked within a universe of funds similar in investment objective as determined by Lipper.
The Lipper scores listed are based on monthly data. Lipper scores are subject to change every month. The Lipper Average is a straight average of the specific Lipper Universe.
This information is provided for educational purposes only and should not be considered investment advice. Lipper rankings are not intended to predict future results, and Lipper does not guarantee the accuracy of this information.  
NFW-1994AO.42




Home
Retirement & Investing
Mutual Funds
Pricing & Performance






Retirement



Retirement Plans
401(k) Plans
403(b) Plans
457 Plans




Mutual Funds
Pricing & Performance
NVIT Funds
Shareholder News




Annuities
Fixed Annuities
Variable Annuities
Immediate Annuities
Fixed Indexed Annuities




Life Insurance
Term Life Insurance
Whole Life Insurance
Universal Life Insurance
Variable Universal Life Insurance






NFW-4371AO.6


﻿






























Abbott Laboratories (NYSE:ABT) Releases Q3 Earnings Guidance - Chaffey Breeze













































 
















 



  
 
 
























Daily Ratings & News for Abbott Laboratories

        
	Complete the form below to receive the latest headlines and analysts' recommendationsfor Abbott Laboratories with our free daily email newsletter:










Follow @chaffeybreeze












Recent Posts

Cincinnati Financial Corporation (NASDAQ:CINF) Shares Sold by Mitchell Mcleod Pugh & Williams Inc.
Fresenius Medical Care Corporation (FMS) Position Maintained by Meyer Handelman Co.
American States Water Company (NYSE:AWR) Stake Maintained by Blackhill Capital Inc.
Prescott Group Capital Management L.L.C. Maintains Position in ServiceSource International, Inc. (NASDAQ:SREV)
Prescott Group Capital Management L.L.C. Reduces Position in Nu Skin Enterprises, Inc. (NYSE:NUS)
Net 1 UEPS Technologies, Inc. (UEPS) Position Increased by Prescott Group Capital Management L.L.C.
Factory Mutual Insurance Co. Has $66,602,000 Position in Zimmer Biomet Holdings, Inc. (ZBH)
LS Investment Advisors LLC Purchases 370 Shares of Western Digital Corporation (WDC)
Genworth Financial Inc (NYSE:GNW) Shares Sold by Mount Vernon Associates Inc. MD
Omnicell, Inc. (OMCL) Shares Bought by Juncture Wealth Strategies LLC
Genesis Asset Managers LLP Buys 2,135,204 Shares of Ultrapar Participacoes S.A. (UGP)
Schneider Downs Wealth Management Advisors LP Has $373,000 Position in Brookfield Infrastructure Partners LP (BIP)
Northwest Investment Counselors LLC Buys 3 Shares of Fair Isaac Corporation (FICO)
Eaton Vance Corporation (EV) Shares Bought by Northwest Investment Counselors LLC
NN Investment Partners Holdings N.V. Buys 202,462 Shares of Regency Centers Corporation (NYSE:REG)
Simon Property Group, Inc. (NYSE:SPG) Shares Bought by NN Investment Partners Holdings N.V.
Northwest Investment Counselors LLC Has $1.63 Million Position in AutoZone, Inc. (AZO)
NN Investment Partners Holdings N.V. Has $58.16 Million Position in Mosaic Company (The) (NYSE:MOS)
PPG Industries, Inc. (PPG) Releases  Earnings Results, Hits Expectations
Abbott Laboratories (NYSE:ABT) Releases Q3 Earnings Guidance







Abbott Laboratories (NYSE:ABT) Releases Q3 Earnings Guidance


					Posted by Charlotte Bryant on Jul 22nd, 2017 // No Comments




Abbott Laboratories (NYSE:ABT) updated its third quarter earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $0.64-0.66 for the period, compared to the Thomson Reuters consensus estimate of $0.66. Abbott Laboratories also updated its FY17 guidance to $2.43-2.53 EPS.
A number of analysts recently weighed in on the company. Stifel Nicolaus  restated a buy rating and issued a $58.00 target price on shares of Abbott Laboratories in a research report on Friday. Cowen and Company  restated an outperform rating and issued a $55.00 target price (up previously from $48.00) on shares of Abbott Laboratories in a research report on Friday, July 14th. BMO Capital Markets  restated a hold rating and issued a $48.00 target price on shares of Abbott Laboratories in a research report on Tuesday, July 11th. Morgan Stanley  restated an equal weight rating on shares of Abbott Laboratories in a research report on Monday, July 10th. Finally, TheStreet upgraded Abbott Laboratories from a c+ rating to a b rating in a research report on Monday, July 3rd. Four research analysts have rated the stock with a hold rating, twelve have issued  a buy rating and one  has given a strong buy rating to the company’s stock. Abbott Laboratories presently has a consensus rating of Buy and a consensus price target of $51.80.


 Get Abbott Laboratories alerts:



Shares of Abbott Laboratories (NYSE ABT) opened at 50.84 on Friday. The firm has a 50-day moving average price of $48.18 and a 200 day moving average price of $44.68. Abbott Laboratories has a 12 month low of $37.38 and a 12 month high of $51.13. The company has a market cap of $88.22 billion, a P/E ratio of 52.90 and a beta of 1.07. 





Abbott Laboratories (NYSE:ABT) last posted its quarterly earnings data on Thursday, July 20th. The healthcare product maker reported $0.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.60 by $0.02. The business had revenue of $6.64 billion during the quarter, compared to analyst estimates of $6.63 billion. Abbott Laboratories had a return on equity of 15.53% and a net margin of 4.96%. The company’s revenue for the quarter was up 24.5% on a year-over-year basis. During the same period last year, the company earned $0.55 EPS.  Equities analysts predict that  Abbott Laboratories will post $2.48 earnings per share for the current year. 
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Friday, July 14th will be paid a $0.265 dividend. This represents a $1.06 annualized dividend and a dividend yield of 2.08%. The ex-dividend date is Wednesday, July 12th. Abbott Laboratories’s payout ratio is 149.30%. 
In other news, insider Stephen R. Fussell sold 196,550 shares of the firm’s stock in a transaction that occurred on Thursday, June 8th. The stock was sold at an average price of $46.00, for a total value of $9,041,300.00. Following the completion of the sale, the insider now directly owns 221,488 shares of the company’s stock, valued at approximately $10,188,448. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jared Watkin sold 552 shares of the firm’s stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $47.97, for a total value of $26,479.44. Following the completion of the sale, the insider now directly owns 47,090 shares of the company’s stock, valued at $2,258,907.30. The disclosure for this sale can be found here. Insiders sold a total of 206,902 shares of company stock valued at $9,497,761 over the last ninety days. Corporate insiders own  0.76% of the company’s stock. 
TRADEMARK VIOLATION NOTICE: This piece of content was first  reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at https://www.chaffeybreeze.com/2017/07/22/abbott-laboratories-nyseabt-releases-q3-earnings-guidance.html. 
About Abbott Laboratories
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States.







Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.








 






















Latest News





Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website












 

 













































Boston Marketing Advisors LLC                                                                                            - Boston                                            , MA         - Company Information









 



























Products
Resources
My Account












Talk to a D&B Advisor 
1-800-280-0780 




Business Directory



MA



Boston



Management Consulting Services



Management Consulting Services



                            Boston Marketing Advisors LLC
                                    



 





















B 


Boston Marketing Advisors LLC                                                                                           
CLAIM THIS BUSINESS



8 FANEUIL HALL SQ BOSTON, MA 02109
Get Directions



(617) 714-3374
 





Business Info



 Founded 2009
 Incorporated MA
 Annual Revenue $430,000.00
 Employee Count 5
 Industries Management Consulting Services
 Contacts Janet Kelly                                                                                                             







Contact Business







Your Email Address

Subject:


Message


Send Message





Company Summary


Boston Marketing Advisors Llc                                                                                            was founded in 2009. The company is located in Boston and incorporated in Massachusetts. Boston Marketing Advisors Llc                                                                                            specializes in Management Consulting Services. 









VERIFIED Status:
UNVERIFIED



Address:
UNVERIFIED





LAST VERIFIED:

                                    --
                                



Phone:

                                    UNVERIFIED
                                





Payment Method:
UNVERIFIED


view full report





Similar Businesses Nearby


                                        Our similar businesses nearby shows similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Competitive Landscape


                                        Our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Payments Accepted

NO DATA



Hours



                                        Sunday 

                                        

                                                                                            --
                                            
                                        



                                        Monday 

                                        

                                                                                            --
                                            
                                        



                                        Tuesday 

                                        

                                                                                            --
                                            
                                        



                                        Wednesday 

                                        

                                                                                            --
                                            
                                        



                                        Thursday 

                                        

                                                                                            --
                                            
                                        



                                        Friday 

                                        

                                                                                            --
                                            
                                        



                                        Saturday 

                                        

                                                                                            --
                                            
                                        







B

VIEW ADDITIONAL DATA                        
Select from over 115 networks below to view available data about this business. If this data is unavailable or inaccurate and you own or represent this business, click here for more information on how you may be able to correct it. 







Credibility Review





Google





Facebook.com





Yellowbook.com





Bing.com





Yellowpages.com





MerchantCircle





Tele Atlas (TomTom)





Twitter.com





AOL





MapQuest





Yahoo Local





Apple/Siri





Groupon





Hotfrog.com





Comcast.net Search





ReachLocal





Admedia





Dealsplus





Shoptopia.com





Alteryx





Dogtime Media





KSL.com





Sirtune





AmericanTowns.com





Driverside





Kudzu.com





SpecialsAgent.com





Answers.com





eGood





LawInfo.com





spotlikes.com





anywho.com





eGumball





Likeness.com





Spotzot





eServiceLog





MapMyRun





TechnoCom





apartmentguide.com





ezlocal.com





EZToUse.com





Teleroute





AroundMe.com





metropolist.com





Therapists.com





Atlanta NewHomes





FindLaw.com





Time Out New York





Avantar





FindTheBest.com





mojopages.com





B2B Yellowpages





Fivestar Software





MyCityWay.com





TripAdvisor





bckyrd.com





GiftCards.com





MyCoupons.com





beachcalifornia.com





GoLocal247.com





mymove.com





UpMeSocial.com





Belo





GoodInfo





News-Gazette





Nokia





usdirectory.com





Cars.com





Nomao





Centzy.com





hibu





Openlist.com





ChaCha Search





Homeplate.com





OwnLocal.com





VisiKard





challama.com





Homestore





patch.com





Voltari





CityBot





Pelopidas





Vouchd





ClassifiedAds





Hostway





PlaceIQ





WalkScore.com





CloudMade





Hoodoyou





PlanetDiscover.com





WeddingWire.com





PowerProfiles





Where Inc.





Contractors.com





iGoLocal.com





Radiate Media





Wikiocity





CouponMap





Indeed.com





Wimgo.com





CrowdSpot





Innova Electronics





Intellistrand





realtor.com





DataSphere





InTheMO.com





Reply.com





Yellowbot.com





JiWire





Rocket Fuel





YellowPageCity.com





DMV.org





Justclicklocal.com





Dirxion





Keen.com





Zidster.com












Photos














































Business Credit Report
Receive a one-time comprehensive credit report on this company.
get full credit report


Facebook








Twitter








Yelp






































Call 1.800.280.0780 to speak with a D&B Advisor Today!







Customer Resources
Products
Education Center
Business Articles & Insights
Glossary
Contact Us
Customer Support
Communication Preferences
Search for D&B D-U-N-S




Our Company
About Us
Company History
Business Credit History
Careers
Press Releases
News
Success Stories
Hoovers




Our Network
Partners
Affiliates
Blog
Access to Capital
Entrepreneurial Initiative
D&B International
SupplierEdge




Site Links
Business Directory
Site Map
PIPEDA
Privacy Policy
Website Terms of Service
Product License Agreement







© Dun & Bradstreet, Inc. 2017. All rights reserved.
















﻿






























Access Financial Services Inc. Has $303,000 Position in Abbott Laboratories (NYSE:ABT) - Chaffey Breeze













































 
















 



  
 
 
























Daily Ratings & News for Abbott Laboratories

        
	Complete the form below to receive the latest headlines and analysts' recommendationsfor Abbott Laboratories with our free daily email newsletter:










Follow @chaffeybreeze












Recent Posts

8,357 Shares in American International Group, Inc. (AIG) Acquired by OLD National Bancorp IN
Vaughan Nelson Investment Management L.P. Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)
Williams-Sonoma, Inc. (NYSE:WSM) Shares Sold by Winslow Evans & Crocker Inc.
Oregon Public Employees Retirement Fund Acquires 12,600 Shares of Mastercard Incorporated (NYSE:MA)
CrestPoint Capital Management LLC Has $3.66 Million Position in Abbott Laboratories (NYSE:ABT)
Pecaut & CO. Reduces Position in The Kraft Heinz Company (NASDAQ:KHC)
Chevron Corporation (NYSE:CVX) Shares Bought by B & T Capital Management DBA Alpha Capital Management
Access Financial Services Inc. Has $303,000 Position in Abbott Laboratories (NYSE:ABT)
LaSalle Hotel Properties (NYSE:LHO) Given Media Impact Rating of 0.10
Invesco PLC (NYSE:IVZ) Receives Daily News Sentiment Rating of 0.17
Merus Labs International (NASDAQ:MSLI) Receiving Somewhat Favorable News Coverage, Report Shows
Liberty Interactive Corporation (NASDAQ:QVCA) Receiving Somewhat Positive Press Coverage, Analysis Shows
Critical Comparison: AptarGroup (NYSE:ATR) vs. BPC Acquisition Corp (BERY)
VWR Corporation (NASDAQ:VWR) Downgraded by Zacks Investment Research to Hold
Zacks Investment Research Downgrades UMB Financial Corporation (NASDAQ:UMBF) to Hold
Pagegroup PLC (LON:PAGE) Price Target Raised to GBX 442
Monster Beverage Corporation (NASDAQ:MNST) Stock Rating Upgraded by Zacks Investment Research
Stock Yards Bancorp, Inc. (NASDAQ:SYBT) Cut to “Sell” at BidaskClub
Williams Partners LP (NYSE:WPZ) Rating Lowered to Hold at Zacks Investment Research
Rosenblatt Securities Initiates Coverage on The Charles Schwab Corporation (SCHW)







Access Financial Services Inc. Has $303,000 Position in Abbott Laboratories (NYSE:ABT)


					Posted by Oliver Carreras on Jul 17th, 2017 // No Comments




Access Financial Services Inc. maintained its stake in  Abbott Laboratories (NYSE:ABT) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor  owned 6,224 shares of the healthcare product maker’s stock at the end of the second quarter. Access Financial Services Inc.’s holdings in Abbott Laboratories were worth $303,000 as of its most recent SEC filing. 
Several other large investors also recently bought and sold shares of the company. Cypress Capital Management LLC WY raised its stake in  Abbott Laboratories by 37.9% in the first quarter. Cypress Capital Management LLC WY now owns 2,531 shares of the healthcare product maker’s stock valued at $112,000 after buying an additional 696 shares during the period.  Feltz Wealth PLAN Inc. bought a new stake in  Abbott Laboratories during the first quarter valued at approximately $112,000.  Advantage Investment Management LLC bought a new stake in  Abbott Laboratories during the fourth quarter valued at approximately $120,000.  First Command Financial Services Inc. raised its stake in  Abbott Laboratories by 10.2% in the first quarter. First Command Financial Services Inc. now owns 2,787 shares of the healthcare product maker’s stock valued at $124,000 after buying an additional 257 shares during the period.  Finally, Menora Mivtachim Holdings LTD. bought a new stake in  Abbott Laboratories during the fourth quarter valued at approximately $129,000. Hedge funds and other institutional investors own  71.02% of the company’s stock. 


 Get Abbott Laboratories alerts:



Abbott Laboratories (NYSE ABT) opened at 48.91 on Monday. Abbott Laboratories has a one year low of $37.38 and a one year high of $49.59. The company has a 50 day moving average of $46.26 and a 200-day moving average of $43.65. The company has a market cap of $84.87 billion, a P/E ratio of 50.89 and a beta of 1.06. 





Abbott Laboratories (NYSE:ABT) last announced its quarterly earnings data on Wednesday, April 19th. The healthcare product maker reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.05. Abbott Laboratories had a net margin of 6.74% and a return on equity of 14.91%. The company had revenue of $6.34 billion during the quarter, compared to analysts’ expectations of $6.16 billion. During the same quarter in the prior year, the company earned $0.41 EPS. Abbott Laboratories’s revenue was up 29.7% compared to the same quarter last year.  On average, equities analysts expect that  Abbott Laboratories will post $2.47 earnings per share for the current fiscal year. 
The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Friday, July 14th will be issued a $0.265 dividend. The ex-dividend date of this dividend is Wednesday, July 12th. This represents a $1.06 annualized dividend and a yield of 2.17%. Abbott Laboratories’s payout ratio is 110.42%. 
ILLEGAL ACTIVITY WARNING: “Access Financial Services Inc. Has $303,000 Position in Abbott Laboratories (NYSE:ABT)” was  posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.chaffeybreeze.com/2017/07/17/access-financial-services-inc-has-303000-position-in-abbott-laboratories-nyseabt.html. 
Several research firms have recently commented on ABT. Royal Bank Of Canada  restated a “buy” rating on shares of Abbott Laboratories in a research note on Monday, May 15th. Jefferies Group LLC  reiterated a “buy” rating and issued a $55.00 price target on shares of Abbott Laboratories in a research note on Friday, June 16th. BTIG Research began coverage on Abbott Laboratories in a research note on Wednesday, June 21st. They issued a “buy” rating and a $56.00 price target for the company. Zacks Investment Research upgraded Abbott Laboratories from a “hold” rating to a “buy” rating and set a $53.00 price target for the company in a research note on Wednesday, June 14th. Finally, BidaskClub upgraded Abbott Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 17th. Four investment analysts have rated the stock with a hold rating, twelve have assigned  a buy rating and one  has assigned  a strong buy rating to the stock. Abbott Laboratories presently has an average rating of “Buy” and an average price target of $51.33.
In other Abbott Laboratories news, insider Joseph J. Manning sold 4,200 shares of the business’s stock in a transaction dated Wednesday, April 26th. The shares were sold at an average price of $43.95, for a total value of $184,590.00. Following the transaction, the insider now directly owns 26,224 shares in the company, valued at approximately $1,152,544.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jared Watkin sold 552 shares of the business’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $47.97, for a total transaction of $26,479.44. Following the completion of the transaction, the insider now owns 47,090 shares in the company, valued at $2,258,907.30. The disclosure for this sale can be found here. Insiders sold a total of 206,902 shares of company stock worth $9,497,761 over the last quarter. 0.76% of the stock is currently owned by company insiders. 
Abbott Laboratories Company Profile
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States.







Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.








 






















Latest News





Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website












 

 













































Boston Advisors, LLC | Wealthminder











































Boston Advisors, LLC


Boston Advisors, LLC
(CRD# 140059) is a financial advisory firm headquartered in
Boston, MA.
They
manage $4,790,175,561 in 1,014 accounts and
serve the financial needs of clients across 51 states (or territories).




Current Firm Details



Boston Advisors, LLC




One Liberty Square,
Boston,
MA
02109
617-348-3100
http://www.bostonadvisors.com




http://www.bostonadvisors.com







By the Numbers






Total Assets Under Management

4,790
MILLION



Total Number of Accounts

1,014
ACCOUNTS



Average Account Value

$4,724,039







Compensation Options




A percentage of assets under your management
Fixed fees (other than subscription fees)






Advisory Services Offered




Portfolio management for individuals and/or small businesses
Portfolio management for investment companies (as well as "business development companies")
Portfolio management for pooled investment vehicles (other than investment companies)
Portfolio management for businesses (other than small businesses) or institutional clients








Types of Clients










Registered States






Registered Investment Advisor


Advisors affiliated with a RIA are permitted to work with up to five clients in nearly-all states* without explicit registration. The map below shows states where this firm has explicit registration only.




AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV






Financial Advisors at Boston Advisors, LLC




Showing 1 - 10 of 18 top financial advisors.





1















James W. Gaul



CRD#:
2915784



One Federal Street,
Boston,
MA
02110




96

Wealthminder
score








James Gaul (CRD# 2915784) is an Investment Advisor Representative working at
Boston Advisors, LLC in Boston, MA and has 
over 17 years
of experience in the finance industry.






2















Lawrence C. Manning



CRD#:
1394158



One Federal Street,
Boston,
MA
02110




96

Wealthminder
score








Lawrence Manning (CRD# 1394158) is an Investment Advisor Representative working at
Boston Advisors, LLC in Boston, MA and has 
over 31 years
of experience in the finance industry.






3















Douglas A. Riley



CRD#:
2056395



One Federal Street,
Boston,
MA
02110




96

Wealthminder
score








Douglas Riley (CRD# 2056395) is an Investment Advisor Representative working at
Boston Advisors, LLC in Boston, MA and has 
over 27 years
of experience in the finance industry.






4















Michael J. Vogelzang



CRD#:
2186136



One Federal Street,
Boston,
MA
02110




96

Wealthminder
score








Michael Vogelzang (CRD# 2186136) is an Investment Advisor Representative working at
Boston Advisors, LLC in Boston, MA and has 
over 25 years
of experience in the finance industry.






5















Peter D. Anderson



CRD#:
3117256



One Federal Street,
Boston,
MA
02110




93

Wealthminder
score








Peter Anderson (CRD# 3117256) is an Investment Advisor Representative working at
Boston Advisors, LLC in Boston, MA and has 
over 7 years
of experience in the finance industry.






6















Steven M. Esielonis



CRD#:
856778



One Liberty Square,
Boston,
MA
02109




93

Wealthminder
score








Steven Esielonis (CRD# 856778) is an Investment Advisor Representative working at
Boston Advisors, LLC in Boston, MA and has 
over 17 years
of experience in the finance industry.






7















Keith E. Faulkner



CRD#:
2605166



One Federal Street,
Boston,
MA
02110




93

Wealthminder
score








Keith Faulkner (CRD# 2605166) is an Investment Advisor Representative working at
Boston Advisors, LLC in Boston, MA and has 
over 22 years
of experience in the finance industry.






8















Donald D. Fox



CRD#:
1908815



One Federal Street,
Boston,
MA
02110




93

Wealthminder
score








Donald Fox (CRD# 1908815) is an Investment Advisor Representative working at
Boston Advisors, LLC in Boston, MA and has 
over 28 years
of experience in the finance industry.






9















David A. Hanna



CRD#:
2105488



One Liberty Square,
Boston,
MA
02109




93

Wealthminder
score








David Hanna (CRD# 2105488) is an Investment Advisor Representative working at
Boston Advisors, LLC in Boston, MA and has 
over 22 years
of experience in the finance industry.






10















Tanya A. Kerrigan



CRD#:
4266832



One Federal Street,
Boston,
MA
02110




93

Wealthminder
score








Tanya Kerrigan (CRD# 4266832) is an Investment Advisor Representative working at
Boston Advisors, LLC in Boston, MA and has 
over 16 years
of experience in the finance industry.







1
2
... Next






Our primary data source is public filings of Form ADV as published by the Securities and Exchange Commission (SEC) and made available in accordance with the Freedom of Information Act (FOIA). Supplementary information may be provided by listed advisors or their representatives.
Because many firms provide a variety of products or services, an individual may or may not be registered to operate under all services provided by the firm.Do not rely solely on the information on this page. The information may be inaccurate, incomplete or outdated. For the most accurate and up-to-date information, please search for the firm or individual on the SEC site at
http://www.adviserinfo.sec.gov/IAPD/Content/Search/iapd_Search.aspx







Ready to hire a financial advisor?

Get competitive proposals from multiple advisors.

















Request Proposals























Timeout!



You have been idle and will be logged out in

seconds.


Stay Logged In
Log Out Now















Working at Boston Advisors | GlassdoorGlassdoor will not work properly unless browser cookie support is enabled. Learn how to enable cookies.Boston AdvisorsKeywordLocation CompaniesJobsCompaniesSalariesInterviewsSearchView Allnum of numClose (Esc) Boston Advisors Logo Boston Advisors Logo Boston Advisors Is this your company?Overview Overview -- Reviews -- Jobs 2 Salaries 1 Inter­views -- Benefits -- PhotosFollowAdd a ReviewFollowAdd a ReviewEnhanced Profile Try Enhanced Profile Free for a MonthExplore the many benefits of having a premium branded profile on Glassdoor, like increased influence and advanced analytics.Get StartedChanges wont be saved until you sign up for an Enhanced Profile subscription. Boston Advisors Overview Work Here? Get a Free Employer AccountWebsitewww.bostonadvisors.comHeadquartersBoston, MASize1 to 50 employeesFounded 2006Type Company - PrivateIndustry UnknownRevenue $5 to $10 million (USD) per yearCompetitors UnknownBoston Advisors ReviewsN/AStarStarStarStarStarRecommend to a friendApprove of CEOCEO0 RatingsView Allnum of numClose (Esc)Boston Advisors Interviews Experience   1 Rating ExperiencePositive100%Neutral0%Negative0% Getting an Interview   1 Interview Review Getting an InterviewCampus Recruiting100% Difficulty   1 Rating 3.0 Average DifficultyHardAverageEasySee MoreSee Less Jun 28, 2017    Boston Advisors LogoInstitutional Equity Team Interview Anonymous Interview Candidate in Boston, MADeclined OfferPositive ExperienceAverage InterviewApplicationI applied through college or university. I interviewed at Boston Advisors (Boston, MA) in May 2017.InterviewI applied through my University's career link and I got an invitation to interview in their Boston office a few days later. Three 20-minute interviews - one behavioral interview session and two interview sessions on past experiences and skills.Interview Questions Q: Describe how you would go about cleaning up a set of data on Excel.   Answer Question Q: What experience do you have with the Bloomberg Terminal?   Answer Question Boston Advisors 2017-06-28 13:30 PDT See All 1 Interviews Boston Advisors Awards & Accolades Let us know if we're missing any workplace or industry recognition – Add AwardsWork at Boston Advisors? Share Your Experiences Boston Advisors LogoBoston AdvisorsStarVery DissatisfiedStarDissatisfiedStarNeutral ("OK")StarSatisfiedStarVery Satisfied  Click to RateStart your review...orAdd a SalaryAdd BenefitsAdd an InterviewAdd a SalaryAdd BenefitsAdd an InterviewCloseOutline of two peoples' headsWork in HR or Marketing?Grow your employer brandUnlock your free employer accountCompanies to Explore Job Seekers Also ViewedPenteraStarStarStarStarStar 7 Reviews Related Job SearchAccount Executive jobsAccount Executive salaries ($47k)Mechanical Engineer jobsMechanical Engineer salaries ($70k)Security Guard jobsSecurity Guard salaries ($21k)Hospitality jobsHospitality salaries ($21k)Truck Driver jobsTruck Driver salaries ($43k)Social Worker jobsSocial Worker salaries ($48k)Human Resource jobsHuman Resource salaries ($55k)Marketing jobsMarketing salaries ($60k)Pharmacy Technician jobsPharmacy Technician salaries ($23k)Accountant jobsAccountant salaries ($50k)Receptionist jobsReceptionist salaries ($24k)IT jobsIT salaries ($60k) 



Yelp










Yelp












Sorry, you’re not allowed to access this page.
Contact Yelp if you keep experiencing issues.


















Bing Places for Business
























































































































Bing
 places for business


Sign in using your




Microsoft Account





Work Account





Google Account





Facebook Account

Don't have an account? Create one.


